書誌事項

Proteases as targets for therapy

contributors, S.S. Abdel-Meguid ... [et al.] ; editors, Klaus von der Helm, Bruce D. Korant, and John C. Cheronis

(Handbook of experimental pharmacology, v. 140)

Springer, c2000

大学図書館所蔵 件 / 25

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathological processes for which effective medications are currently needed and/or being sought after. Although protease inhibitors have been investigated for many years, few have been employed therapeutically. Recent break- through by HIV protease inhibitors as therapeutic drugs has re-encouraged the search for inhibitors of other proteolytic enzymes. Klaus von der Helm, who described the first viral protease has brought leading experts together to discuss not only the success and problems of clinical use and continuing prospects, but to review further potential drug targets. This volume provides detailed information and evaluations of key viral, bacterial, fungal, and cellular proteases as potential future drug candidates.

目次

I: HIV Protease Inhibitors (PI) * II: Other Viral (Non-HIV) Protease Inhibitors * III: (Non-Viral) Proteases Involved in Diseases.

「Nielsen BookData」 より

関連文献: 1件中  1-1を表示

詳細情報

  • NII書誌ID(NCID)
    BA44811514
  • ISBN
    • 3540661182
  • 出版国コード
    gw
  • タイトル言語コード
    eng
  • 本文言語コード
    eng
  • 出版地
    Berlin
  • ページ数/冊数
    xxviii, 410 p.
  • 大きさ
    25 cm
  • 親書誌ID
ページトップへ